Company / Interest Expense per Share
Arbutus Biopharma Corp Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2023
5-year range
$0.00 / $0.03
FY2019-FY2023
Trend
-75.5%
vs FY2022
Sector context
#38 of 43
Health Care
What the data says
Arbutus Biopharma Corp's interest expense per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2023). Interest Expense per Share has declined for 3 consecutive years, from $0.03 in FY2020 to $0.00 in FY2023.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -9.3%.
Improved from $0.03 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -55.3%
- 5-Year CAGR
- -9.3%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.00 Sector average $18.61
▼
-100.0% below sector average
Key checks
Key Insights
- Arbutus Biopharma Corp's interest expense per share has declined for 3 consecutive years.
- In FY2023, interest expense per share decreased 75.5% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -75.5% |
| FY2022 | $0.01 | -62.6% |
| FY2021 | $0.03 | -2.1% |
| FY2020 | $0.03 | +699.4% |
| FY2019 | $0.00 | -14.1% |
| FY2018 | $0.00 | +0.0% |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026